Stockreport

U.S. patent court rejects Alvogen's challenge for Celgene's Revlimid [Reuters (UK)]

CELGENE  (CELG) 
Last celgene earnings: 10/31 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.celgene.com
PDF U.S. patent court rejects Alvogen's challenge for Celgene's Revlimid | Reuters 1 Min Read (Reuters) - A U.S. administrative court on Thursday rejected a filing by Alvoge [Read more]